Navigation Links
Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
Date:11/1/2007

COLUMBIA, Md., Nov. 1 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced that a judge in the United States District Court in Wilmington, Delaware, has ruled on various post-trial motions and will enter a permanent injunction in Martek's favor against the defendants in the patent infringement suit brought by Martek against Lonza, Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties & Food Ingredients GmbH. The suit involves Lonza's U.S. sale and use of a fatty acid product currently marketed under the brand name Lonza DHA for use in functional foods and dietary supplements and does not involve Martek's core infant formula patents.

The judge upheld the October 2006 jury verdict that the defendants infringed all of the asserted claims of U.S. Patent Nos. 5,340,594 and 6,410,281 (the "'281 Patent") and that these patents were valid. The judge indicated that he will grant a permanent injunction against Lonza with respect to those two patents. The judge also upheld the jury verdict that Lonza had acted willfully in its infringement of the '281 Patent. Regarding the third patent involved in the case, U.S. Patent No. 6,451,567 (the "'567 Patent"), the judge reversed the jury verdict and found that there was insufficient evidence to show that the claims of this patent are enforceable against the defendants. Martek does not believe that this decision will have an adverse effect on the strength of the permanent injunction to be issued by the Court.

Martek expects that Lonza will appeal the adverse decision against it to the U.S. Court of Appeals for the Federal Circuit. The permanent injunction will be in effect pending any appeal. Martek is considering the alternatives availa
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Quality assurance of RNA derived from laser microdissected tissue samples obtained by the PALM MicroBeam System using the RNA 6000 Pico LabChip kit.
2. High Electrotransformation Efficiencies Obtained With DNA From Ligation Mixtures
3. Obtaining a contour map from multifiles or 3D data in DataMax
4. Third Wave strikes deal with Kaiser Permanente on cystic fibrosis reagents
5. Third Wave sued by one firm; gets injunction against another
6. Protector RNase Inhibitor Enhance the Protection of RNA against Degradation
7. Protecting your business against online brand abuse
8. NovaScan decides against tax credits
9. Journalist warns against late arrival to the tech party
10. Wisconsin companies on the front lines in the war against cancer
11. Guarding against patent enforcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... SEATTLE, Dec. 11 Dendreon Corporation (Nasdaq: ... of its previously announced public offering have exercised ... 2,250,000 shares of common stock at the public ... exercise of the option increases the size of ... of common stock. Dendreon expects to receive ...
(Date:12/11/2009)... -- Algeta ASA (OSE: ALGETA), the,cancer therapeutics ... in the,US, the Tulane Cancer Center, New ... III clinical study of Alpharadin in men ... that has metastasized to the skeleton. , ... in SYMptomatic Prostate CAncer) study is a,double-blind, ...
(Date:12/10/2009)... (Nasdaq: DNDN ) announced today that it has ... its common stock at a price to the public ... the underwriters a 30-day option to purchase up to ... overallotments, if any. The offering is expected to ... conditions. ,, J. P. Morgan Securities Inc. and Deutsche ...
(Date:12/10/2009)... Dec. 10 Newly published research, ... Stem Cell Institute (NESCI) in the journal ... of eight patients with "Limbal Stem Cell ... cells without the need of suppressing their ... ,, LSCD is a painful, blinding disease ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4
... ALBUQUERQUE, N.M., Dec. 12 Biomoda, Inc. (OTC,Bulletin ... and New,Mexico Institute of Mining and Technology (New ... today to collaborate on clinical,studies and the development ... company,s commercialization of its assay for the early,detection ...
... , - Forty-five Prestigious Journals to be ... Elsevier, a leading publisher of scientific, technical and ... journals,from Elsevier Masson will be available on ScienceDirect ... de Radiologie, Journal de Chirurgie and,La Press Medicale, ...
... Dec. 11 The Tauri Group LLC is ... provide Systems Engineering and,Technical Assistance (SETA) support for ... Health Affairs Early Detection Division Chemical,and Biological Early ... $38 million and the period of performance is ...
Other Biology Technology:Biomoda Announces Collaborative Agreement With New Mexico Tech 2ScienceDirect to Host French-Language Journals from Elsevier Masson 2ScienceDirect to Host French-Language Journals from Elsevier Masson 3The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract 2
(Date:12/14/2009)... a novel antifreeze molecule in a freeze-tolerant Alaska beetle ... Unlike all previously described biological antifreezes that contain protein, ... protein. It is composed of a sugar and a ... the cells of organisms. , "The most exciting ... a whole new kind of antifreeze that may work ...
(Date:12/14/2009)... Biomedical Engineering Society (BMES) have founded a new journal ... CVET is a forum for research ... The first issue of the new quarterly journal ... BMES publications at Springer, Annals of Biomedical Engineering ... Cardiovascular Engineering and Technology will present a ...
(Date:12/14/2009)... Astrobiology Centre (INTA-CSIC) has shown that hydrogen cyanide, urea ... the most basic biological molecules can be obtained from ... this study, published in the journal Chemistry & ... the early Earth. , "We have shown that when ... hydrogen cyanide, a substance that could have played a ...
Breaking Biology News(10 mins):Scientists isolate new antifreeze molecule in Alaska beetle 2Biomedical Engineering Society's new journal to be published by Springer 2Prussian blue linked to the origin of life 2Using Your Immune System to Fight Cancer 58734 1Food 4 Less Stores Giving Hope a Hand 28R 29 in October by Supporting Breast Cancer Awareness Initiatives 58729 1Food 4 Less Stores Giving Hope a Hand 28R 29 in October by Supporting Breast Cancer Awareness Initiatives 58729 2Food 4 Less Stores Giving Hope a Hand 28R 29 in October by Supporting Breast Cancer Awareness Initiatives 58729 3Micro shuttle drug delivery could mean an end to regular dosing 14326 1Micro shuttle drug delivery could mean an end to regular dosing 14326 2
... laser therapy that destroys cancer cells but leaves healthy ... a study published in the Aug. 1 online edition ... (PNAS). , "One of the longstanding problems in medicine ... tissue," says Hongjie Dai, an associate professor of chemistry ...
... practice, government and industry are coming together for ... rapidly growing area of medicine involving minimally invasive ... two days of the meeting focus on treatments ... second half of the meeting provides an opportunity ...
... inhaled form of anthrax disarms bacteria-fighting white blood cells before ... within days. , The lethal toxin in anthrax paralyzes neutrophils, ... defense against infection, by impairing how they build tiny filaments ... eat invading bacteria. , Just two hours of exposure to ...
Other Biology News:Scientists develop nanotech-laser treatment that kills cancer cells without harming healthy tissue 2Scientists develop nanotech-laser treatment that kills cancer cells without harming healthy tissue 3Scientists develop nanotech-laser treatment that kills cancer cells without harming healthy tissue 4Minimally Invasive Cancer Treatments Highlighted 2Minimally Invasive Cancer Treatments Highlighted 3Anthrax stops body from fighting back, study shows 2Anthrax stops body from fighting back, study shows 3
... engineered for efficient drying down of synthetic ... cover and a post-trap with ammonia neutralizing ... of samples in ammonium hydroxide., , ... , Comes standard with ...
... The first SpeedVac to have active, real-time ... SpeedVac System is the worlds first, fully ... can be stacked together to form an ... benchspace. It is also the first SpeedVac ...
... Acid Resistant SpeedVac Model SPD131DDA , ... , The SPD131DDA is designed to handle the ... a new slim design, digital display, dual independent ... TEFLON coated chamber and vapor pathway. , , ...
... Psychology, The University of New South Wales, Sydney, ... Perth, Australia This is the Fourth Edition of ... It is a large format version (330 ... compact 3rd edition. This product number includes ...
Biology Products: